Russia's Sputnik V Covid vaccine found safe in mid-stage trial in India: Dr Reddy's

- The company has submitted the mid-stage trial safety data to India's drug regulator for review and approval to continue late-stage trials, Dr Reddy's said in a regulatory filing
- Data and safety monitoring board recommended phase 3 recruitment and continue Sputnik V clinical trial without any modifications